Konstan, M., Wagener, J., Yegin, A., Millar, S., Pasta, D., & VanDevanter, D. (2010). DESIGN AND POWERING OF CYSTIC FIBROSIS CLINICAL TRIALS USING RATE OF FEV(1) DECLINE AS AN EFFICACY ENDPOINT.
Trích dẫn kiểu ChicagoKonstan, MW, JS Wagener, A. Yegin, SJ Millar, DJ Pasta, và DR VanDevanter. DESIGN AND POWERING OF CYSTIC FIBROSIS CLINICAL TRIALS USING RATE OF FEV(1) DECLINE AS AN EFFICACY ENDPOINT. 2010.
Trích dẫn MLAKonstan, MW, et al. DESIGN AND POWERING OF CYSTIC FIBROSIS CLINICAL TRIALS USING RATE OF FEV(1) DECLINE AS AN EFFICACY ENDPOINT. 2010.
Cảnh báo: Các trích dẫn này có thể không phải lúc nào cũng chính xác 100%.